ARCC will again be offering travel support (up to $1000) for students presenting at our conference. To be eligible for a student travel award, the student must be submitting an abstract to and presenting at the ARCC2019. The application for student travel awards is electronic and will only be available in parallel with abstract submission. If you have any questions, please contact ARCC@cancercare.on.ca
To Apply: The application for Student Travel Awards is now closed. Applicants will receive decision notification in mid March, 2019.
contact ARCC@cancercare.on.ca for more information
The 2019 ARCC Conference will be hosted at the Halifax Convention Centre, in Halifax, Nova Scotia.
Registration for the 2019 ARCC Conference is now open! Early bird rates are in effect until April 19, 2019
Early-Bird Member – $100
Early-Bird Non-Member – $200
Early-Bird Student (member) – $50
Early-Bird Student (non-member) – $100
New-Professional* (members only) – $50
Industry – $500
**If you are a new professional (within 5 years of receiving your terminal degree) please email ARCC@cancercare.on.ca with your graduation details to be eligible for a special registration code providing a 50% discount on registration!!!
Special rates have been negotiated with local hotels on behalf of the 2019 ARCC and CAHSPR conferences. Use the links below to make your reservations and get the best rates at ideal locations close to the Halifax Convention Centre. Additional properties expected to be added in February 2019
- Four Points by Sheraton Halifax – 1496 Hollis Street Halifax, Nova Scotia B3J 3Z1
Rate: $194/night. Book Directly at https://www.marriott.com/event-reservations/reservation-link.mi?id=1808207762&key=20B836D&app=resvlink
- Residence Inn by Marriott Halifax Downtown – 1599 Grafton Street, Halifax, Nova Scotia B3J 2C3
Rate: $195/night. Book Directly at https://www.marriott.com/event-reservations/reservation-link.mi?id=1549650811695&key=GRP&app=resvlink
The Canadian Centre for Applied Research in Cancer Control (ARCC) is pleased to announce that its 8th annual conference, ARCC 2019, will take place from May 27th to 28th at the Halifax Convention Centre in Halifax, Nova Scotia. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
Canada’s Applied Research in Cancer Control Conference
Halifax Convention Centre
1650 Argyle Street
Halifax, Nova Scotia
Stay tuned for additional speakers and information!
Division Manager, Breast Cancer Screening Program/Cervical Screening Initiatives Program, Eastern Health
Nicholas Latimer, BSc, MSc, PhD
Nick joined the School of Health and Related Research (ScHARR) at the University of Sheffield in June 2008. Before this he graduated with a degree in economics from the University of Nottingham in 2003 and an MSc in Health Economics from the University of York in 2004. Nick has experience in both public and private sectors having previously worked as an Analyst at NERA Economic Consulting, a Health Economics Fellow at Queen Mary, University of London (QMUL), and a Health Economist at Roche Products Ltd.
Much of Nick’s work focuses on the incorporation of survival analysis in economic evaluations – particularly the use of statistical methods for adjusting survival estimates in the presence of treatment switching in clinical trials. Nick works closely with the NICE Decision Support Unit (DSU) and has authored three DSU technical support documents (TSD) on survival analysis (TSD14), the use of treatment switching adjustment methods in the context of economic evaluation (TSD16), and partitioned survival modelling (TSD19). He has led the Evidence Review Group (ERG) on NICE Technology Appraisals, has contributed to NICE Public Health guidelines, and has conducted several economic evaluations alongside clinical trials.
Nick has completed NIHR Doctoral and Post-Doctoral Fellowships on the topics of survival analysis, treatment switching and economic evaluation. He is currently a Yorkshire Cancer Research Senior Fellow.
Nick is a current member of NICE Technology Appraisal Committee B. He has been an invited expert on the NICE Scientific Advice Programme and is a member of the Health Economists Study Group, and a Fellow of the Higher Education Academy. Nick teaches Economic Evaluation and survival analysis to MSc students.
Anthony B. Miller, MD, FRCP, FRCP(C), FFPH, FACE
Professor Emeritus, Dalla Lana School of Public Health, University of Toronto. A physician-epidemiologist, he was trained in internal medicine, and was a member of the scientific staff of the Tuberculosis and Chest Diseases Research Unit, UK Medical Research Council, 1962-71. He was Director of the Epidemiology Unit of the National Cancer Institute of Canada 1971-86 and Chair of the Department of Preventive Medicine and Biostatistics, University of Toronto, 1992-6. He served as a special expert in the Division of Cancer Prevention, US National Cancer Institute, 1997, Senior Epidemiologist, International Agency for Research on Cancer 1998-9, Head, Division of Epidemiology, German Cancer Research Centre, Heidelberg, 2000-3, Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, 2008-10. He has been a consultant to the World Health Organization. He is Scientific Lead of the OncoSim microsimulation modelling initiative of the Canadian Partnership Against Cancer. His research encompasses cancer etiology, prevention and screening.
Maciej Niewada, MD MSc PhD
http://www.healthquest.pl/ More Information coming soon!
Jennifer Payne, PhD
Dr. Jennifer Payne is both a Senior Epidemiologist with the Nova Scotia Breast Screening Program and an Associate Professor in the Department of Diagnostic Radiology at Dalhousie University where her research program focuses on the utilization of breast imaging procedures. For 6 years, she chaired the Monitoring & Evaluation Working Group of the Canadian Breast Cancer Screening Network at CPAC, overseeing the submission of provincial/territorial screen-level data to the Canadian Breast Cancer Screening Database at PHAC and the production of associated surveillance reports by CPAC.
Jean Seely, MDCM, FRCPC
https://med.uottawa.ca/radiology/people/seely-jean-0 More Information coming soon!
Dr. Kelvin Chan, MD, FRCP, MSc, PhD - (ARCC Co-Director)
Dr Kelvin Chan is a medical oncologist at the Sunnybrook Odette Cancer Centre, an Associate Professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and Head and Neck oncology. He has recently completed his PhD in Biostatistics (focusing on statistical methods in health economic evaluations) at the Dalla Lana School of Public Health, University of Toronto.
As a clinical epidemiologist and biostatistician, Dr. Chan’s research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), funded by the Canadian Cancer Society (CCS).
Professionally, Dr Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including membership at the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drug (CED) and the Interim Chair for the Ontario Steering Committee of Cancer Drugs (OSCCD), Ontario MOHLTC and Cancer Care Ontario. He is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Cancer Care Ontario (CCO).
Dr. Stuart Peacock, PhD - (ARCC Co-Director)
Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship and is a Professor in the Faculty of Health Sciences, Simon Fraser University. He is currently Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also a Distinguished Scientist in Cancer Control Research at the BC Cancer Agency, a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Over the past 20 years, Stuart’s main research interests have focused on research into developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors.
Dr. Dominika Wranik, PhD
Dr. Dominika Wranik is an Associate Professor at the School of Public Administration at Dalhousie University, a health economist and health policy researcher. Her research over the past decade has focused on the remuneration of primary health care providers, as well as on solutions to health human resource shortages in Canada. In a consulting capacity, she has worked collaboratively with public sector decision makers, including Health Canada, the Public Health Agency of Canada, the Nova Scotia Department of Health and Wellness, Manitoba Health, and Alberta Health.
Dr. Tallal Younis, MBBCh, FRCP(UK), FACP
Dr. Tallal Younis is a medical oncologist, professor in the Division of Medical Oncology, a Dalhousie University clinical research scholar, and a Beatrice Hunter Cancer Research Institute senior scientist. He is co-chair of the provincial breast cancer site team and a member of the Canadian Cancer Society Research Institute’s working group on economic analysis.